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Insulin-like growth factor I1 (IGF-11) is highly expressed at  the mRNA and protein 
levels in SH-SYSY human neuroblastoma SH-SYSY cells also express type I 
and type I1 IGF and respond to IGF-I1 with increased DNA synthesis 
and neurite outgrowth> suggesting the presence of an IGF-11-mediated autocrine 
growth mechanism. Based on these results, we hypothesized that the rate of 
SH-SYSY cell proliferation is partly determined by the level of IGF-I1 gene 
expression, and that IGF-I1 expression may be serum dependent. We tested this 
hypothesis using northern analysis to determine the effects of removal and subse- 




FIGURE 1. Northern analysis of IGF-I1 mRNA. SH-SY5Y cells were plated (3.7 x loh 
cells/cm2 in TI50 flasks) and cultured for 2 days in 10% calf serum and DMEM. Cells were 
rinsed with DMEM, and DMEM added. After 1 day, the medium was removed and DMEM + 
10% calf serum added. RNA was isolated either before serum removal (no rinse), 1 day after 
serum (S) deprivation, or 1, 2, 3, or  4 days after transfer back to serum, as indicated in the 
legend. Total RNA was electrophoresed and northern analysis performed as described,2 with 
"P-cDNA labeled probes for human IGF-I1 and p-actin. 
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quent addition of serum on cultured SH-SYSY cell IGF-I1 mRNA levels. RNA was 
analyzed from cells that were serum deprived for one day or cells that were serum 
deprived and subsequently transferred to serum-containing media for one to four 
days. 
SH-SYSY cells expressed three IGF-I1 mRNA transcripts (1.8, 4.8, and 6.0 kb), 
of which the 6.0-kb transcript was the most abundant, as previously described.2 A 
2.1-kb p-actin mRNA was also detected, and served as a control for the amount of 
FIGURE 2. Densitometric analysis of IGF-I1 mRNA. Optical densities of the 6.0-kb IGF-I1 
and 2.1 kb p-actin bands for each lane of several autoradiographs like that shown in FIGURE 1 
were densitometrically quantitated, and IGF-I1 mRNA expressed as a percentage of the 
untreated control relative to p-actin. *p < 0.05 relative to untreated, day 0 control levels by 
unpaired, two-tailed r-test. 
RNA loaded onto the gel. Levels of the 6.0-kb IGF-I1 mRNA increased by 6-fold 
after a one-day serum deprivation (FIGURES 1 and 2, lanes 1 and 2). One day 
following the subsequent addition of serum to SH-SYSY cells, IGF-I1 mRNA was 
reduced to 3-fold above untreated control levels (FIGURES 1 and 2, lanes 1 and 3). 
Two, three, or four days after subsequent serum addition, SH-SYSY cell IGF-I1 
mRNA levels were not significantly different from untreated control levels (FIGURES 
1 and 2, compare lane 1 with lanes 3,4,5, and 6). 
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These observations indicate that steady-state IGF-I1 mRNA levels increase with 
serum removal and are partially reversed by the addition of serum. IGF-I1 mRNA 
transcripts in stably transfected mouse cells are differentially expressed in a serum- 
dependent f a ~ h i o n . ~  We observed no changes in the relative abundance of the three 
IGF-I1 mRNA transcripts in human SH-SYSY cells, suggesting that species-specific 
(mouse vs. human) factors may be important in the regulation of IGF-I1 gene 
expression. 
In summary, we found that IGF-I1 mRNA levels in SH-SYSY cclls are increased 
with serum deprivation, and partially reversed to untreated control levels by subse- 
quent addition of serum-containing media. Regulation of IGF-I1 gene expression by 
serum may be associated with changes in SH-SYSY cell growth. Indeed, we have 
shown elsewhere that IGF-I1 gene expression is decreased with growth inhibition by 
the cytokine interferon-?.' 
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